FrancophonIA/ELRC3.0 huggingface dataset:
English: The primary composite efficacy endpoint was the time to the first occurrence of any of the following events: Cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, or hospitalisation for unstable angina.
Slovenian: Primarni sestavljeni opazovani dogodek učinkovitosti je bil čas do prvega pojava katerega koli od naslednjih dogodkov: srčno-žilne smrti, miokardnega infarkta brez smrtnega izida, možganske kapi brez smrtnega izida ali sprejema v bolnišnico zaradi nestabilne angine pektoris.
English: Your thumb could block the dose selector from turning.
Slovenian: S palcem namreč lahko onemogočite obračanje izbirnika odmerka.
English: • You are taking or have stopped taking certain other medicines (see section 2, "Other medicines and Suliqua").
Slovenian: • Jemljete ali ste nehali jemati določena druga zdravila (glejte poglavje 2, "Druga zdravila in zdravilo Suliqua").
English: You should test your blood sugar straight away after taking glucose to check that you really have hypoglycaemia.
Slovenian: Krvni sladkor si morate izmeriti takoj po zaužitju glukoze; tako boste preverili, da res imate hipoglikemijo.
English: Some (1.7%) patients taking insulin containing therapy, including Suliqua have experienced erythema, local edema, and pruritus at the site of injection.
Slovenian: Pri nekaterih (1,7 %) bolnikih, ki so prejemali zdravljenje, ki vsebuje insulin, vključno z zdravilom Suliqua, so se pojavili pordelost, lokalna oteklina in srbenje na mestu injiciranja.
English: • Patient Guide.
Slovenian: • Vodnik za bolnike.
English: Do not return the pen to a refrigerator and do not freeze.
Slovenian: Peresnika ne dajte nazaj v hladilnik in ga ne zamrznite.
English: Based on your lifestyle, your blood sugar tests and your previous insulin use, your doctor will tell you:
Slovenian: Zdravnik vam bo glede na vaš slog življenja, izvide meritev krvnega sladkorja in prejšnjo uporabo insulina povedal:
English: If your blood sugar is too high (hyperglycaemia), you may not have injected enough insulin.
Slovenian: Če imate previsok krvni sladkor (hiperglikemijo), si morda niste injicirali dovolj insulina.
English: D. Pull off the inner needle cap and throw away.
Slovenian: D. Snemite notranji pokrovček igle in ga zavrzite.
English: The medicine may not work very well.
Slovenian: Delovanje zdravila se lahko poslabša.
English: The median duration of study follow-up was 25.8 and 25.7 months in the lixisenatide group and the placebo group, respectively.
Slovenian: Mediano spremljanje v študiji je trajalo v skupini z liksisenatidom 25,8 mesece in v skupini s placebom 25,7 meseca.
English: Check your blood sugar and eat more food to prevent your blood sugar getting too low (hypoglycaemia).
Slovenian: Merite si krvni sladkor in jejte več hrane, da boste preprečili preveliko znižanje krvnega sladkorja (hipoglikemijo).
English: To avoid dosing errors and potential overdose, neither the patients nor healthcare professionals should ever use a syringe to draw the medicinal product from the cartridge in the pre-filled pen into a syringe.
Slovenian: Da ne bi prišlo do napak pri odmerjanju in možnega prevelikega odmerjanja, ne smejo bolniki ali zdravstveno osebje nikdar uporabiti brizge, da bi zdravilo iz vložka napolnjenega injekcijskega peresnika potegnili v brizgo.
English: • Fibrates, for lowering high levels of blood fats.
Slovenian: • Fibrate, za znižanje visoke koncentracije maščob v krvi.
English: • When medicine comes out of the needle tip, your pen is working correctly, the dose selector will be reset to “0”.
Slovenian: • Če iz konice igle priteče zdravilo, peresnik deluje pravilno; izbirnik odmerka se bo pomaknil nazaj na "0".
English: Lixisenatide is a glucagon-like peptide (GLP1) receptor agonist.
Slovenian: Liksisenatid je agonist receptorjev glukagonu podobnega peptida (GLP1).
English: Sanofi-Aventis Deutschland GmbH Industriepark Höchst - 65926 Frankfurt am Main Germany
Slovenian: Sanofi-Aventis Deutschland GmbH Industriepark Höchst - 65926 Frankfurt am Main Nemčija
English: • You inject too much Suliqua.
Slovenian: • Injicirali ste si preveč zdravila Suliqua.
English: Ask your pharmacist how to throw away medicines you no longer used.
Slovenian: O načinu odstranjevanja zdravila, ki ga ne uporabljate več, se posvetujte s farmacevtom .
English: After multiple-dose administration in patients with type2 diabetes, mean terminal half-life was approximately 3 hours and the mean apparent clearance (CL/F) about 35 L/h.
Slovenian: Po uporabi več odmerkov pri sladkornih bolnikih tipa 2 je bil povprečni terminalni razpolovni čas približno 3 ure in povprečni navidezni očistek (CL/F) približno 35 l/uro.
English: C. Throw away the used needle in a puncture resistant container (see “Throwing your pen away” at the end of this Instructions for Use).
Slovenian: C. Uporabljeno iglo zavrzite v vsebnik, odporen proti prebadanju (glejte "Kako zavreči peresnik" na koncu teh navodil).
English: (-0.21 to 0.43)
Slovenian: (-0,21 do 0,43)
English: • Pentamidine, for some parasite infections.
Slovenian: • Pentamidin, za nekatere okužbe z zajedavci.
English: Use Suliqua once a day, within 1 hour before a meal.
Slovenian: Zdravilo Suliqua uporabljajte enkrat na dan, 1 uro pred jedjo.
English: A. Select 2 dose steps by turning the dose selector until the dose pointer is at the 2 mark.
Slovenian: A. Izberite 2 odmerna koraka tako, da zavrtite izbirnik odmerka, dokler kazalnik odmerka ne kaže oznake 2.
English: Documented symptomatic or severe hypoglycaemic adverse reactions
Slovenian: Dokumentirane simptomatske ali hude hipoglikemije
English: In controlled clinical trials in adults with insulin glargine (100 units/ml), subgroup analyses based on age, race, and gender did not show differences in safety and efficacy.
Slovenian: V kontroliranih kliničnih preskušanjih insulina glargin (100 enot/ml) analize podskupin glede na starost, raso in spol niso pokazale razlik v varnosti in učinkovitosti.
English: If a patient wishes to become pregnant, or pregnancy occurs, treatment with Suliqua should be discontinued.
Slovenian: Če bolnica želi zanositi ali če zanosi, je treba zdravljenje z zdravilom Suliqua prekiniti.
English: Insulin inhibits lipolysis and proteolysis, and enhances protein synthesis.
Slovenian: Insulin zavira lipolizo in proteolizo in pospešuje sintezo beljakovin.
English: Following administration of a single dose of paracetamol 1000 mg, paracetamol AUC and t1/2 were unchanged whatever the timing of its administration (before or after the lixisenatide injection).
Slovenian: Po uporabi enkratnega odmerka 1000 mg paracetamola se AUC in t1/2 paracetamola ne glede na čas njegove uporabe (pred injiciranjem liksisenatida ali po njem) nista spremenila.
English: With Suliqua, it may take longer to recover from low blood sugar because it contains a long-acting insulin (insulin glargine).
Slovenian: Med zdravljenjem z zdravilom Suliqua lahko okrevanje po nizkem krvnem sladkorju traja dalj časa, ker to zdravilo vsebuje dolgodelujoč insulin (insulin glargin).
English: In patients treated with Suliqua, the incidence of related nausea, diarrhoea and vomiting was 8.4%, 2.2% and 2.2%, respectively.
Slovenian: Pri bolnikih, zdravljenih z zdravilom Suliqua, je bila incidenca s tem povezane navzee 8,4 %, driske 2,2 % in bruhanja 2,2 %.
English: [1.4 to 2.6]
Slovenian: [1,4 do 2,6]
English: These other medicines may include oral anti-diabetics (such as metformin, sulfonylurea medicines) or insulin.
Slovenian: Med temi drugimi zdravili so lahko peroralni antidiabetiki (na primer metformin ali sulfonilsečnine) ali insulin.
English: • Keep new pens in the refrigerator between 2°C to 8°C.
Slovenian: • Nove peresnike shranjujte v hladilniku na temperaturi od 2 do 8 °C.
English: • A safety test must be performed before each injection.
Slovenian: • Pred vsakim injiciranjem morate opraviti varnostni preizkus.
English: • Throw away the used needle in a sharps container, or as told by your pharmacist or local authority.
Slovenian: • Uporabljene igle zavrzite v vsebnik za ostre odpadke, ali kot vam naroči farmacevt ali pristojni lokalni organ.
English: Gastrointestinal adverse reactions (nausea, vomiting and diarrhoea) were frequently reported adverse reactions during the treatment period.
Slovenian: Neželeni učinki na prebavilih (navzea, bruhanje ali driska) so bili med obdobjem zdravljenja pogosto zabeleženi neželeni učinki.
English: The incidence of MACE was similar between LANTUS and standard care in ORIGIN [Hazard Ratio (95% CI) for MACE; 1.02 (0.94, 1.11)].
Slovenian: Incidenca MACE je bila v študiji ORIGIN v skupini z zdravilom LANTUS podobna kot v skupini z običajnim zdravljenjem [razmerje ogroženosti (95 % IZ) za MACE; 1,02 (0,94, 1,11)].
English: • Diazoxide, for high blood pressure.
Slovenian: • Diazoksid, za visok krvni tlak.
English: In the event of blocked needles, patients must follow the instructions described in the Instructions for Use accompanying the package leaflet (see section 6.6).
Slovenian: Če je igla zamašena, mora bolnik slediti navodilom, opisanim v navodilih za uporabo, priloženih navodilu za uporabo zdravila (glejte poglavje 6.6).
English: • you have type 1 diabetes, as Suliqua is used for type 2 diabetes and this medicine will not be right for you.
Slovenian: • če imate sladkorno bolezen tipa 1, kajti zdravilo Suliqua se uporablja za zdravljenje sladkorne bolezni tipa 2 in tako ni primerno za vas.
English: There are no adequate data from the use of lixisenatide in pregnant women.
Slovenian: O uporabi liksisenatida pri nosečnicah ni dovolj podatkov.
English: The reduction in Cmax is of limited clinical relevance and no dose adjustment for oral contraceptives is required.
Slovenian: Znižanje Cmax je klinično malo pomembno in odmerka kontraceptivov ni treba prilagoditi.
English: [-0.420 to 0.038]
Slovenian: [-0,420 do 0,038]
English: Type I colourless glass cartridge with a black plunger (bromobutyl rubber) and a flanged cap (aluminium) with inserted laminated sealing disks (bromobutyl rubber on the medicinal product side and polyisoprene on the outside) containing 3 ml of solution.
Slovenian: Vložek iz brezbarvnega stekla tipa I s črnim batom (iz brombutilne gume) in obrobljeno zaporko (aluminij) z vstavljenimi laminiranimi zapornimi diski (brombutilna guma na strani zdravila in poliizopren na zunanji strani), ki vsebujejo 3 ml raztopine.
English: Exposure to insulin glargine following administration of the insulin glargine/lixisenatide combination was 86-88 % compared to administration of separate simultaneous injections of insulin glargine and lixisenatide.
Slovenian: Izpostavljenost insulinu glargin po uporabi kombinacije insulin glargin/liksisenatid je bila od 86 do 88 % v primerjavi s sočasno uporabo ločenih injekcij insulina glargin in liksisenatida.
English: For oral medicinal products that are particularly dependent on threshold concentrations for efficacy, such as antibiotics, patients should be advised to take those medicinal products at least 1 hour before or 4 hours after lixisenatide injection.
Slovenian: Za peroralna zdravila, katerih učinkovitost je zlasti odvisna od mejnih koncentracij, kot so antibiotiki, moramo bolnikom svetovati, naj takšna zdravila vzamejo vsaj 1 uro pred injiciranjem liksisenatida ali 4 ure po injiciranju.
English: Other signs include: headaches, feeling very hungry, feeling sick (nausea) or being sick (vomiting), feeling tired, sleepy, restless, sleeping problems, aggressive behaviour, difficulty concentrating, slow reactions, depression, feeling confused, difficulty speaking (sometimes total loss of speech), changes in your sight, trembling, being unable to move (paralysis), tingling in the hands or arms, feeling numb and tingling often around the mouth, feeling dizzy, loss of self-control, being unable to look after yourself, fits, passing out.
Slovenian: Med drugimi znaki so glavobol, huda lakota, slabost v želodcu (siljenje na bruhanje) ali bruhanje, utrujenost, zaspanost, nemir, težave s spanjem, agresivno vedenje, težave z zbranostjo, počasne reakcije, potrtost, občutek zmedenosti, težave z govorom (včasih popolna izguba govora), spremembe vida, tresenje, nezmožnost gibanja (paraliza), mravljinčenje v rokah ali dlaneh, omrtvičenost in mravljinčenje, pogosto okrog ust, omotičnost, izguba samonadzora, nezmožnost poskrbeti zase, napadi krčev, nezavest.
English: • Tell patients to closely monitor their blood sugar levels when starting insulin glargine/lixisenatide which contains insulin glargine and a non-insulin active substance (lixisenatide).
Slovenian: • Bolnikom naročite, naj natančno spremljajo koncentracijo krvnega sladkorja, ko začnejo zdravljenje z insulinom glarginom/liksisenatidom, ki vsebuje insulin glargin in neinsulinsko učinkovino (liksisenatid).
English: Suliqua has not been studied in patients with severe gastrointestinal disease, including severe gastroparesis and therefore, the use of Suliqua is not recommended in these patients.
Slovenian: Zdravilo Suliqua ni raziskano pri bolnikih s hudo boleznijo prebavil, vključno s hudo gastroparezo, zato ga pri takšnih bolnikih ni priporočljivo uporabljati.
English: It must only be used if the solution is clear, colourless, with no solid particles visible, and if it is of water-like consistency.
Slovenian: Uporabite ga le, če je raztopina v njem bistra, brezbarvna, ne vsebuje vidnih trdnih delcev in je vodi podobne gostote.
English: A metabolism study in diabetic patients who received insulin glargine alone indicates that insulin glargine is rapidly metabolised at the carboxyl terminus of the B chain to form two active metabolites, M1 (21A-Gly-insulin) and M2 (21A-Gly-des-30B-Thr-insulin).
Slovenian: Študija presnove pri sladkornih bolnikih, ki so prejemali samo insulin glargin, je pokazala, da se insulin glargin hitro presnovi na karboksilnem koncu verige B. Tako nastaneta dva aktivna presnovka, M1 (21A-Gly-insulin) in M2 (21A-Gly-des-30B-Thr-insulin).
English: If your blood sugar gets too low, see the advice in the box at the end of this leaflet.
Slovenian: Če se vam krvni sladkor preveč zniža, glejte nasvet v okviru na koncu tega navodila.
English: Following administration of a single dose of an oral contraceptive medicinal product (ethinylestradiol 0.03 mg/levonorgestrel 0.15 mg) 1 hour before or 11 hours after 10 mcg lixisenatide, the Cmax, AUC, t1/2 and tmax of ethinylestradiol and levonorgestrel were unchanged.
Slovenian: Po uporabi enkratnega odmerka peroralnega kontraceptiva (0,03 mg etinilestradiola in 0,15 mg levonorgestrela) 1 uro pred ali 11 ur po 10 mcg liksisenatida se Cmax, AUC, t1/2 in tmax etinilestradiola in levonorgestrela niso spremenili.
English: Suliqua must not be mixed with any other insulin or diluted.
Slovenian: Zdravila Suliqua se ne sme mešati z nobenim drugim insulinom in se ga ne sme redčiti.
English: Some medicines can change your blood sugar level.
Slovenian: Nekatera zdravila lahko spremenijo koncentracijo sladkorja v krvi.
English: At the end of the run-in period, patients who remained inadequately controlled (HbA1c between 7% and 10%) were randomised to either Suliqua, insulin glargine or lixisenatide.
Slovenian: Na koncu obdobja uvajanja so bolnike, ki so ostali neustrezno urejeni (HbA1c med 7 % in 10 %), randomizirali ali na zdravilo Suliqua ali na insulin glargin ali na liksisenatid.
English: Based on these results, no dose adjustment for warfarin is required when co-administered with lixisenatide; however, frequent monitoring of INR in patients on warfarin and/or coumarin derivatives is recommended at the time of initiation or ending of lixisenatide treatment.
Slovenian: Na podlagi teh rezultatov odmerka varfarina med sočasno uporabo z liksisenatidom ni treba prilagoditi, je pa v času uvedbe ali končanja zdravljenja z liksisenatidom priporočljivo pogosto kontrolirati INR bolnikov, ki prejemajo varfarin in/ali kumarinske derivate.
English: Needles must not be re-used.
Slovenian: Igel se ne sme ponovno uporabiti.
English: • For twice daily basal insulin or insulin glargine (300 units/ml), the total daily dose previously used should be reduced by 20% to choose the Suliqua starting dose.
Slovenian: • V primeru predhodne uporabe bazalnega insulina ali insulina glargin (300 enot/ml) dvakrat na dan je treba za izbiro začetnega odmerka zdravila Suliqua celotni predhodno uporabljani dnevni odmerek zmanjšati za 20 %.
English: Suliqua is not recommended in women of childbearing potential not using contraception.
Slovenian: Zdravila Suliqua ni priporočljivo uporabljati pri ženskah v rodni dobi, ki ne uporabljajo kontracepcije.
English: This can help to spot mild hypoglycaemic episodes.
Slovenian: To lahko pomaga odkriti blage hipoglikemije.
English: • Patients who are blind or with poor vision must be instructed to always get assistance from another person who has good vision and is trained in using insulin glargine/lixisenatide pen device.
Slovenian: • Slepim ali slabovidnim bolnikom je treba naročiti, da morajo vedno dobiti pomoč druge osebe, ki dobro vidi in je usposobljena za uporabo napolnjenega injekcijskega peresnika z insulinom glarginom/liksisenatidom.
English: The following table describes the rate of documented symptomatic hypoglycaemia (≤3.9 mmol/L) and severe hypoglycaemia for both Suliqua and the comparator.
Slovenian: Naslednja preglednica prikazuje delež dokumentiranih simptomatskih hipoglikemij (≤ 3,9 mmol/l) in hudih hipoglikemij z zdravilom Suliqua in primerjalnim zdravilom.
English: In rare cases, the presence of such antibodies may necessitate adjustment of the Suliqua dose in order to correct a tendency for hyperglycaemia or hypoglycaemia.
Slovenian: V redkih primerih je zaradi prisotnosti takšnih protiteles treba prilagoditi odmerek zdravila Suliqua, da bi odpravili nagnjenost k hiperglikemiji ali hipoglikemiji.
English: Since Suliqua may cause stomach side effects, the medicine has not been studied in patients with severe stomach or gut problems.
Slovenian: Ker lahko zdravilo Suliqua povzroča neželene učinke na prebavilih, ni raziskano pri bolnikih s hudimi težavami z želodcem ali črevesjem.
English: Results at 30 weeks - Add-on to metformin clinical study (mITT population) Suliqua
Slovenian: Rezultati po 30 tednih - Klinična študija dodatka metforminu (populacija mZNZ) Zdravilo Suliqua
English: This type 2 diabetes population had the following characteristics: Mean age was 60.0 years with the majority (56.3%) being aged of 50 to 64 years, and 53.3 percent were female.
Slovenian: Ta populacija s sladkorno boleznijo tipa 2 je imela naslednje značilnosti: povprečna starost je bila 60,0 let; večina bolnikov (56,3 %) je bila starih od 50 do 64 let.
English: These factors include: - change in the injection area - improved insulin sensitivity (e.g. by removal of stress factors) - unaccustomed, increased or prolonged physical activity - intercurrent illness (e.g. vomiting, diarrhoea) - inadequate food intake - missed meals - alcohol consumption - certain uncompensated endocrine disorders, (e.g. in hypothyroidism and in anterior pituitary or adrenocortical insufficiency) - concomitant treatment with certain other medicinal products (see section 4.5).
Slovenian: Med takšnimi dejavniki so: - sprememba predela injiciranja, - izboljšana občutljivost za insulin (npr. zaradi odstranitve stresnih dejavnikov), - nevajena, intenzivnejša ali dolgotrajnejša telesna dejavnost, - sočasna bolezen (npr. bruhanje, driska), - nezadostno uživanje hrane, - izpuščeni obroki, - pitje alkohola, - določene nekompenzirane endokrine motnje (npr. hipotiroidizem, insuficienca sprednjega režnja hipofize ali insuficienca skorje nadledvične žleze), - sočasno zdravljenje z določenimi drugimi zdravili (glejte poglavje 4.5).
English: As lixisenatide is cleared primarily by the kidney, no pharmacokinetic study has been performed in patients with acute or chronic hepatic impairment.
Slovenian: Liksisenatid se odstrani predvsem skozi ledvice, zato farmakokinetičnih študij pri bolnikih z akutno ali kronično okvaro jeter niso izvedli.
English: Turn the dose selector until the dose pointer lines up with your dose.
Slovenian: Zavrtite izbirnik odmerka, dokler kazalnik odmerka ni nastavljen na vaš odmerek.
English: No animal studies have been conducted with the combination of insulin glargine and lixisenatide to evaluate repeated dose toxicity, carcinogenesis, genotoxicity, or toxicity to reproduction.
Slovenian: Na živalih niso izvedli študij s kombinacijo insulina glargin in liksisenatida za oceno toksičnosti ponavljajočih odmerkov, kancerogenosti, genotoksičnosti ali vpliva na sposobnost razmnoževanja.
English: A. Take a new needle and peel off the protective seal.
Slovenian: A. Vzemite novo iglo in odstranite zaščitno prelepko.
English: In addition, under the influence of sympatholytic medicinal products such as beta-blockers, clonidine, guanethidine and reserpine, the signs of adrenergic counter-regulation may be reduced or absent.
Slovenian: Poleg tega se lahko pod vplivom simpatikolitičnih zdravil, npr. antagonistov adrenergičnih receptorjev beta, klonidina, gvanetidina in rezerpina, znaki adrenergične protiregulacije zmanjšajo ali izginejo.
English: It is given, with metformin, when other medicines are not enough on their own to control your blood sugar levels.
Slovenian: Uporablja se, skupaj z metforminom, če druga zdravila sama ne zadoščajo za obvladovanje koncentracije krvnega sladkorja.
English: The most frequently reported adverse reactions during treatment with Suliqua were hypoglycaemia and gastrointestinal adverse reactions (see section 'Description of selected adverse reactions' below).
Slovenian: Najpogostejši neželeni učinki med zdravljenjem z zdravilom Suliqua so bili hipoglikemija in neželeni učinki na prebavilih (glejte poglavje "Opis izbranih neželenih učinkov", spodaj).
English: The MAH shall ensure that, in each Member State where Suliqua is marketed, all healthcare professionals who are expected to prescribe, dispense and patients who are expected to use Suliqua, have access to/are provided with the following educational package:
Slovenian: Imetnik dovoljenja za promet z zdravilom bo v vseh državah članicah, kjer bo zdravilo Suliqua na trgu, poskrbel, da bodo vsi zdravstveni delavci, ki bodo predvidoma predpisovali ali izdajali to zdravilo, in vsi bolniki, ki ga bodo predvidoma uporabljali, imeli dostop do naslednjega izobraževalnega kompleta oziroma bodo dobili ta komplet:
English: There is no experience with Suliqua in children and adolescents aged less than 18 years, therefore, the use of Suliqua is not recommended in this age group.
Slovenian: Izkušenj z zdravilom Suliqua pri otrocih in mladostnikih, mlajših od 18 let, ni, zato zdravila Suliqua v tej starostni skupini ni priporočljivo uporabljati.
English: For more information, see the box at the end of this leaflet.
Slovenian: Za več informacij glejte okvir na koncu tega navodila.
English: • The prescription should mention the pre-filled pen type you need (Suliqua 10-40 pen or 30-60 pen) and the number of dose steps to be injected.
Slovenian: • Na receptu mora biti navedena vrsta napolnjenega injekcijskega peresnika, ki jo potrebujete (peresnik Suliqua 10-40 ali peresnik Suliqua 30-60) in število odmernih korakov, ki jih morate injicirati.
English: Hypoglycaemia may occur if the dose of Suliqua is higher than required.
Slovenian: Hipoglikemija se lahko pojavi, če je odmerek zdravila Suliqua večji, kot je potrebno.
English: E. After holding and slowly counting to 10, release the injection button.
Slovenian: E. Potem, ko ste gumb držali in počasi prešteli do 10, gumb za injiciranje spustite.
English: It is not known if Suliqua passes into your milk.
Slovenian: Ni znano, ali zdravilo Suliqua prehaja v materino mleko.
English: • you have severe kidney disease or you are on dialysis as the use of this medicine will not be recommended.
Slovenian: • če imate hudo bolezen ledvic ali ste na dializi, ker uporaba tega zdravila v tem primeru ni priporočljiva.
English: If you have kidney or liver problems If you have kidney or liver problems, talk to your doctor as you may need a lower dose.
Slovenian: Če imate težave z ledvicami ali jetri, se posvetujte z zdravnikom, ker boste morda potrebovali manjši odmerek.
English: This pen is olive coloured with a brown injection button.
Slovenian: Ta peresnik je olivne barve in ima rjav gumb za injiciranje.